 |
Immucor to Host Debt Investor Conference Call on Wednesday, April 24, 2013
Apr 17, 2013
|
5.9 KB |
|
| |
NORCROSS, Ga., April 17, 2013 - Immucor, Inc., a global leader in transfusion and transplantation diagnostics, today announced that it will hold a conference call with debt investors on Wednesday, April 24 at 1:00 p.m. ET to discuss its fiscal 2013 third quarter results.
Interested debt investors and analysts should contact Immucor I...
|
|
Immucor Completes Acquisition of LIFECODES® Business from Hologic, Inc.
Mar 22, 2013
|
7.6 KB |
|
| |
NORCROSS, Ga., March 22, 2013 - Immucor, Inc., a global leader in providing automated instrument-reagent systems to the blood transfusion industry, has completed its acquisition of the LIFECODES business from Hologic, Inc. (NASDAQ: HOLX).
"The addition of LIFECODES expands Immucor's specialty diagnostic footprint with a highly ...
|
|
Immucor to Host Debt Investor Conference Call on Wednesday, January 16, 2013
Jan 11, 2013
|
5.8 KB |
|
| |
NORCROSS, Ga., January 11, 2013 - Immucor, Inc., a global leader in providing automated instrument-reagent systems to the blood transfusion industry, today announced that it will hold a conference call with debt investors on Wednesday, January 16 at 1:00 p.m. ET to discuss its fiscal 2013 second quarter results.
Interested debt inve...
|
| |
Immucor to Acquire the LIFECODES® Business from Hologic, Inc.
Jan 3, 2013
|
435.5 KB |
|
|
Immucor, Inc., Launches Enhanced Customer Education Platform For The Blood Banking Community
Dec 11, 2012
|
6.2 KB |
|
| |
Norcross, GA, December 11, 2012 — Immucor, Inc., announced the launch of its innovative e-learning customer education platform, Lab Education And Resource Network (LEARN). LEARN enables blood bank professionals to gain knowledge about their field and connect with peers through interactive case studies and online educational materials. The LEA...
|
|
Immucor Updates Debt Investor Conference Call to Tuesday, August 7
Aug 2, 2012
|
6.0 KB |
|
| |
NORCROSS, Ga., August 2, 2012 - Immucor, Inc., a global leader in providing automated instrument-reagent systems to the blood transfusion industry, today announced that it has moved its debt investor conference call to discuss fiscal 2012 fourth quarter results to an earlier date. Immucor will now hold its conference call with debt investors on ...
|
|
Immucor to Host Debt Holder Conference Call on Monday, November 14
Oct 31, 2011
|
5.9 KB |
|
| |
NORCROSS, Ga., October 31, 2011 - Immucor, Inc., a global leader in providing automated instrument-reagent systems to the blood transfusion industry, today announced that it will hold a conference call with its debt holders on Monday, November 14 at 1 p.m. ET to discuss its fiscal 2012 first quarter results.
Interested debt investor...
|
|
William A. Hawkins Appointed New CEO of Immucor
Oct 6, 2011
|
7.5 KB |
|
| |
ATLANTA, Oct. 6, 2011 (GLOBE NEWSWIRE) -- The Board of Directors of Immucor, Inc. announced today that William A. Hawkins will be Immucor's next CEO. Immucor, Inc. is a private company, wholly owned by TPG Capital. Mr. Hawkins' appointment follows the decision of current CEO Joshua Levine to step down from his role. The transition will be effect...
|
|
IVD Acquisition Corporation Successfully Completes Acquisition of Immucor
Aug 19, 2011
|
10.9 KB |
|
| |
NORCROSS, Ga. and FORT WORTH, Texas, Aug. 19, 2011 (GLOBE NEWSWIRE) -- Immucor, Inc. (Nasdaq:BLUD) (the "Company") and TPG Capital, L.P. ("TPG Capital") today announced the successful acquisition of the Company by IVD Acquisition Corporation, an affiliate of TPG Capital, for $27.00 per share in cash, or approximately $1.939 billion in the aggregate...
|
|
Immucor Announces End of "Go-Shop" Period
Aug 16, 2011
|
13.4 KB |
|
| |
NORCROSS, Ga., Aug. 16, 2011 (GLOBE NEWSWIRE) -- Immucor, Inc. (Nasdaq:BLUD) ("Immucor" or the "Company"), today announced the expiration of the "go-shop" period pursuant to the terms of the previously announced merger agreement, dated as of July 2, 2011, which contemplates the acquisition of the Company by an affiliate of TPG Capital, L.P. ("TPG C...
|
|
Immucor and IVD Acquisition Corporation Announce German Antitrust and Merger Control Clearance
Aug 4, 2011
|
14.0 KB |
|
| |
NORCROSS, Ga. and FORT WORTH, Texas, Aug. 4, 2011 (GLOBE NEWSWIRE) -- Immucor, Inc. (Nasdaq:BLUD) (the "Company") and IVD Acquisition Corporation, an affiliate of TPG Capital, L.P. ("TPG Capital"), today announced that Germany's Federal Cartel Office has granted clearance in connection with IVD Acquisition Corporation's previously announced transac...
|
|
Immucor and IVD Acquisition Corporation Announce Expiration of HSR Waiting Period
Aug 3, 2011
|
13.9 KB |
|
| |
NORCROSS, Ga. and FORT WORTH, Texas, Aug. 3, 2011 (GLOBE NEWSWIRE) -- Immucor, Inc. (Nasdaq:BLUD) (the "Company") and IVD Acquisition Corporation, an affiliate of TPG Capital, L.P. ("TPG Capital"), today announced the expiration of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended (the "HSR Act"), relatin...
|
|
IVD Acquisition Corporation Commences Tender Offer for All Shares of Immucor, Inc.
Jul 15, 2011
|
13.8 KB |
|
| |
NORCROSS, Ga. and FORT WORTH, Texas, July 15, 2011 (GLOBE NEWSWIRE) -- Immucor, Inc. (Nasdaq:BLUD) (the "Company") and IVD Acquisition Corporation, an affiliate of TPG Capital, L.P. ("TPG"), today announced that IVD Acquisition Corporation has commenced the previously-announced tender offer for all of the outstanding shares of common stock of Immuc...
|
|
Immucor Enters Into Definitive Agreement to be Acquired by TPG Capital
Jul 5, 2011
|
14.6 KB |
|
| |
NORCROSS, Ga., July 5, 2011 (GLOBE NEWSWIRE) -- Immucor, Inc. (Nasdaq:BLUD) (the "Company"), a global leader in providing automated instrument-reagent systems to the blood transfusion industry, today announced that it has entered into a definitive agreement to be acquired by investment funds managed by TPG Capital ("TPG") in a transaction with a fu...
|
|
Immucor CEO Dr. Gioacchino De Chirico Announces Retirement; Board Appoints Joshua H. Levine CEO and Director
Jun 12, 2011
|
10.1 KB |
|
| |
NORCROSS, Ga., June 12, 2011 (GLOBE NEWSWIRE) -- Immucor, Inc. (Nasdaq:BLUD), a global leader in providing automated instrument-reagent systems to the blood transfusion industry, today announced that Dr. Gioacchino De Chirico has stepped down as President and Chief Executive Officer and as a director of the Company. Effective today, Joshua H. Levin...
|
|
Immucor Announces Senior Management Change
Apr 14, 2011
|
6.1 KB |
|
| |
NORCROSS, Ga., April 14, 2011 (GLOBE NEWSWIRE) -- Immucor, Inc. (Nasdaq:BLUD), a global leader in providing automated instrument-reagent systems to the blood transfusion industry, today announced that Geoffrey S. Crouse has resigned as Chief Operating Officer, effective immediately.
"We would like to thank Geoff for his contribution and wis...
|
|
Immucor Announces Fiscal Third Quarter Results
Apr 6, 2011
|
23.4 KB |
|
| |
NORCROSS, Ga., April 6, 2011 (GLOBE NEWSWIRE) -- Immucor, Inc. (Nasdaq:BLUD), a global leader in providing automated instrument-reagent systems to the blood transfusion industry, today reported financial results for its fiscal 2011 third quarter ended February 28, 2011.
Highlights
Revenue for the third quarter of fiscal 2011 w...
|
|
Immucor to Announce Fiscal Third Quarter 2011 Financial Results on Wednesday, April 6, 2011
Mar 23, 2011
|
6.8 KB |
|
| |
NORCROSS, Ga., March 23, 2011 (GLOBE NEWSWIRE) -- Immucor, Inc. (Nasdaq:BLUD), a global leader in providing automated instrument-reagent systems to the blood transfusion industry, today announced that it will release its fiscal 2011 third quarter earnings on Wednesday, April 6, 2011 after the market close. The Company will host a conference call on...
|
|
Immucor to Present at the RBC Capital Markets' Healthcare Conference
Feb 23, 2011
|
6.7 KB |
|
| |
NORCROSS, Ga., Feb. 23, 2011 (GLOBE NEWSWIRE) -- Immucor, Inc. (Nasdaq:BLUD), a global leader in providing automated instrument-reagent systems to the blood transfusion industry, today announced that access to its presentation at the 2011 RBC Capital Markets' Healthcare Conference in New York, NY will be available via a live, simultaneous webcast.
...
|
|
Immucor Announces Fiscal Second Quarter Results
Jan 6, 2011
|
22.7 KB |
|
| |
NORCROSS, Ga., Jan. 6, 2011 (GLOBE NEWSWIRE) -- Immucor, Inc. (Nasdaq:BLUD), a global leader in providing automated instrument-reagent systems to the blood transfusion industry, today reported financial results for its fiscal 2011 second quarter ended November 30, 2010.
Highlights
Revenue for the second quarter of fiscal 2011 ...
|
|
|
Delicious
Digg
Facebook
LinkedIn
Twitter